Company Filing History:
Years Active: 2004-2006
Title: Heui Keun Kang: Innovator in Monoclonal Antibody Research
Introduction
Heui Keun Kang is a prominent inventor based in Uiwang-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 4 patents to his name, Kang's work is paving the way for advancements in medical treatments.
Latest Patents
Kang's latest patents focus on the variable region of monoclonal antibodies against the hepatitis B virus (HBV) S-surface antigen. His inventions include a variable region of the monoclonal antibody and a gene encoding the same. Additionally, he has developed a recombinant vector containing this gene and a transformant obtained from the recombinant vector. These innovations are crucial for enhancing the efficacy of treatments against hepatitis B.
Career Highlights
Heui Keun Kang is currently associated with Yuhan Corporation, a leading pharmaceutical company in South Korea. His work at Yuhan Corporation has allowed him to collaborate with other talented researchers and contribute to groundbreaking advancements in the field of immunology.
Collaborations
Kang has worked alongside notable colleagues such as Jong Wook Lee and In Young Ko. Their collaborative efforts have further enriched the research environment and fostered innovation in their projects.
Conclusion
Heui Keun Kang's contributions to monoclonal antibody research are noteworthy and demonstrate his commitment to advancing medical science. His innovative patents and collaborations position him as a key figure in the biotechnology sector.